Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
M
Nation / PlaceMZ

Mozambique

Southern African state with high cholera and HIV burden; selected for the ARILAC AMR programme in 2026.

Last refreshed: 7 May 2026 · Appears in 1 active topic

Key Question

Does Mozambique's dual cholera and HIV burden make it the ARILAC participant with the most urgent AMR surveillance need?

Timeline for Mozambique

View full timeline →
Common Questions
Why does Mozambique have such a high cholera problem?
Mozambique's cholera burden is driven by inadequate sanitation infrastructure and exacerbated by cyclones. Cyclone Idai in 2019 caused major flooding that triggered a large outbreak, illustrating the climate-disease link in the country.
What is Mozambique's role in the ARILAC programme?
Mozambique is one of eight AU member states selected for ARILAC, launched 6 May 2026, to build antimicrobial resistance laboratory capacity. Its dual cholera and HIV burden make it one of the participants with the most pressing surveillance need.Source: Africa CDC

Background

Mozambique is a Southern African country on the Indian Ocean coast, bordered by Tanzania, Malawi, Zambia, Zimbabwe, South Africa, and Eswatini. Its population of approximately 34 million (2024 estimate) makes it one of the larger countries in the southern African region. Maputo is the capital. Mozambique gained independence from Portugal in 1975 after a prolonged liberation war and subsequently suffered a severe civil conflict until 1992. Natural disasters have been a recurring crisis: Cyclone Idai in 2019 and Cyclone Kenneth the same year caused catastrophic flooding. The country has significant offshore natural gas reserves whose development has been disrupted by an Islamist insurgency in Cabo Delgado province in the north. Mozambique ranks among the countries with the highest HIV prevalence globally.

Mozambique carries a dual burden that makes AMR surveillance particularly urgent: one of sub-Saharan Africa's highest HIV prevalence rates and a history of major cholera outbreaks, most recently amplified by Cyclone Idai's flooding in 2019. Both conditions generate substantial antibiotic pressure with limited capacity to monitor resistance patterns. Mozambique is one of eight AU member states selected for ARILAC (Advancing Regional Integrated Laboratory Capacity for AMR Control), launched in Addis Ababa on 6 May 2026 . The four-year programme will work to establish routine AMR testing infrastructure across human and animal health, addressing one of the most significant blind spots in Mozambique's public health system.

Source Material